Does New Jersey Medicaid cover Ozempic or Wegovy or Rybelsus for weight loss?

Other indications only. Covered when clinically appropriate for cardiovascular disease

Does New Jersey Medicaid cover Mounjaro or Zepbound for weight loss?

Other indications only. Covered for sleep apnea

Medicaid coverage

New Jersey: what Medicaid covers

New Jersey told its own legislature that the program covers weight-loss drugs only in limited circumstances: the approved indications other than weight loss, and children, where federal EPSDT rules require it. A widely republished tracker lists New Jersey among twelve states covering Zepbound for obesity, which is not what the state says.

Checked against the primary source August 25, 2026

What Medicaid in New Jersey covers, and the criteria that apply.
Drug	Position	Criteria
Semaglutide	Other indications only	Covered when clinically appropriate for cardiovascular disease
Tirzepatide	Other indications only	Covered for sleep apnea
Liraglutide	not checked	The memo names Wegovy and Zepbound as examples and does not name Saxenda

Semaglutide Other indications only

Covered when clinically appropriate for cardiovascular disease
Tirzepatide Other indications only

Covered for sleep apnea
Liraglutide not checked

The memo names Wegovy and Zepbound as examples and does not name Saxenda

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1
NJ FamilyCare Coverage of Weight Loss Drugs
New Jersey Department of Human Services, Division of Medical Assistance and Health Services Primary text read and checked Checked August 25, 2026